1 / 5

North America In-vitro Diagnostics Market to witness 5.6% CAGR by 2024

Increasing geriatric population preferring personalised medicines will boost North America in-vitro diagnostics market growth. Geriatric population in the U.S. is around 46 million that is forecasted to double by 2060.

madhurip3918
Download Presentation

North America In-vitro Diagnostics Market to witness 5.6% CAGR by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. North America In-vitro Diagnostics Market to reach USD 39bn by 2024: Graphical Research ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. Key Insights from North America In-vitro Diagnostics Market : • Graphical Research says, North America In-vitro Diagnostics Market to reach USD39bnby 2024 • Integration of advanced technology within the diagnostic devices will improve accuracy and efficiency of these devices that should have a positive impact on in-vitro diagnostics industry growth. • Technologically advanced countries such as the U.S. and Canada focus their efforts on R&D to manufacture automated laboratory diagnostic machines and equipment for accurate detection of diseases. • In-vitro diagnostics market should grow significantly as a result of increasing prevalence of chronic diseases such as diabetes and cancer. As reported by National Cancer Institute, in 2018, there will be 1,735,350 cases of cancer that will escalate the business growth significantly in the near future. • Reagents & kits segment will grow at 6.6% during the forecast timeframe owing to escalating demand for such product types used in diagnosis of viral, fungal and bacterial diseases. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Continued... • Data management software segment accounted for 20.7% revenue share in 2017. • Molecular diagnostics technology segment will grow at 8.3% CAGR over the forecast timeframe. • Diabetes segment was valued at USD 3.9 billion in 2017 and is expected to have high growth rate as a result of growing prevalence of diabetes in developed countries due to increasing incidences of obesity amongst the individuals. • Point-of-care segment had enormous market size of USD 6.2 billion in 2017 and the high growth of the segment can be accounted to the growing use of point-of care molecular diagnostic devices for detecting blood glucose levels even at home. • U.S. in-vitro diagnostics market should witness high growth and held a momentous share of USD 23.9 billion. • Key industry competitors operating in North America in-vitro diagnostics market are Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. Browse Full Market Research Report On North America In-vitro Diagnostics Market @ https://bit.ly/2NUnZTf Request for a Sample of this Research Report @ https://bit.ly/2PepUhM ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related